Atrial fibrillation in older adults with cancer
Manish Kumar1
Nerea Lopetegui-Lia2
Christina Al Malouf3
Mansour Almnajam1
Patrick P.Coll4
Agnes S.Kim1
1.Department of Medicine,Pat and Jim Calhoun Cardiology Center,University of Connecticut School of Medicine,Farmington,CT 06030,USA2.Department of Hematology and Oncology,Cleveland Clinic,Ohio 44195,USA3.De-partment of Cardiology,Mount Sinai Hospital/Icahn School of Medicine,New York 10029,USA4.Department of Fam-ily Medicine,UConn Center of Aging,University of Connecticut,School of Medicine,Farmington,CT 06030,USA
摘要：Cancer and atrial fibrillation (AF) are common co-morbid conditions in older adults. Both cancer and cancer treatment increase the risk of developing new AF which increases morbidity and mortality. Heart rate and rhythm control along with anticoagulation therapy remain the mainstay of treatment of AF in older adults with both cancer and AF. Adjustments to the treatment may be necessary because of drug interactions with concurrent chemotherapy. Cancer and old age increase the risk of both, thromboembolism and bleeding. The risk of these complications is further enhanced by concomitant cancer therapy, frailty, poor nutrition status and, coexisting geriatric syndromes. Therefore, careful attention needs to be given to the risks and benefits of using anticoagulant medications. This review focuses on the management of AF in older patients with cancer, including at the end-of-life care.
机标关键词：cancerwithadultsatrialfibrillationolder
论文发表日期：2022-01-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：8( 1-8 )